ESCs used to fight diabetes; Texas woos new research facility;

Stem Cell Research

Scientists at Edinburgh University have been advancing their work using ESCs to cure diabetes. Report

Scientists from The Forsyth Institute, working with collaborators at Tufts and Tuebingen Universities, have disrupted a natural bioelectrical mechanism within frog embryonic stem cells and trigged a cancer-like response. This research shows that electrical signals are a powerful control mechanism that can be used to modulate cell behavior. Release

The San Jose Mercury News delves into the promise and pitfalls presented by California's $3 billion stem cell initiative. Report

A German group has harvested stem cells from the biopsies of testicles. Story

Genetics

Scientists at deCODE genetics have report the discovery of common versions of two single-letter variations in the human genome (SNPs) that confer risk of basal cell carcinoma, the most common cancer among people of European ancestry. Release

Wisconsin Governor Jim Doyle has announced a collaboration between four Wisconsin research institutions to advance personalized health care. Report

Researchers at McGill University have found a genetic glitch that is responsible for a seven-fold increase in the risk of male pattern baldness. Report

A team of clinicians and scientists at the University of Southampton has identified a major new genetic association with age-related macular degeneration, the most common cause of blindness in developed countries. Release

Cancer Research

An experimental anti-cancer drug can prevent--and even reverse--potentially fatal cardiovascular damage in a mouse model of progeria, a rare genetic disorder that causes the most dramatic form of human premature aging, National Institutes of Health (NIH) researchers reported today. Report

A professor at UT Dallas is using magnetic nanoparticles to fight cancer. Report

More Research

Texas has committed more than $100 million to win a planned National Bio and Agro-Defence facility for San Antonio. Story

Suggested Articles

UPMC researchers are planning clinical trials of a COVID-19 vaccine that uses pieces of the virus' spike protein to create immunity.

Treating mice with niacin increased the number of immune cells in glioblastomas, reducing tumor size and extending survival.

Efforts to pivot existing discoveries into COVID-19 cures may not bear fruit until the pandemic has ended but could help fend off future outbreaks.